volume 27, issue 6, P824-826 2013
DOI: 10.3109/02688697.2013.798857
View full text
|
Sign up to set email alerts
|
Share

Abstract: We report the first case of primary central nervous system lymphoma (PCNSL) developing in a patient with rheumatoid arthritis (RA) undergoing low-dose methotrexate therapy (LD-MTX). The characteristic clinical management and course in our experience of the present case illustrate the important points about PCNSL in methotrexate-associated lymphoproliferative disorders (MTX-LPD). The number of cases of MTX-LPD in RA patients may increase in the future, since current treatment strategies for RA recommend startin…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
13
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals